Héloïse M. Leclair

519 total citations
12 papers, 396 citations indexed

About

Héloïse M. Leclair is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Héloïse M. Leclair has authored 12 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 3 papers in Immunology. Recurrent topics in Héloïse M. Leclair's work include Melanoma and MAPK Pathways (4 papers), Viral-associated cancers and disorders (2 papers) and Peptidase Inhibition and Analysis (2 papers). Héloïse M. Leclair is often cited by papers focused on Melanoma and MAPK Pathways (4 papers), Viral-associated cancers and disorders (2 papers) and Peptidase Inhibition and Analysis (2 papers). Héloïse M. Leclair collaborates with scholars based in France, Belgium and United States. Héloïse M. Leclair's co-authors include Julie Gavard, Nicolas Bidère, Sonia M. Dubois, Catherine Alexia, Karin Tarte, Sandy Azzi, Marie‐Dominique Galibert, Sébastien Corre, Lucas Treps and Elizabeth Harford‐Wright and has published in prestigious journals such as Nature Communications, Blood and Brain.

In The Last Decade

Héloïse M. Leclair

12 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Héloïse M. Leclair France 11 220 127 90 86 58 12 396
Takayuki Tsujioka Japan 13 230 1.0× 78 0.6× 90 1.0× 62 0.7× 74 1.3× 31 489
Riccardo Ferro United Kingdom 10 188 0.9× 41 0.3× 95 1.1× 63 0.7× 86 1.5× 13 362
Satoko Masuda Japan 12 234 1.1× 98 0.8× 56 0.6× 54 0.6× 24 0.4× 15 461
Bin Yuan China 11 167 0.8× 102 0.8× 137 1.5× 43 0.5× 27 0.5× 19 410
Hui‐Jun Mu China 13 220 1.0× 58 0.5× 83 0.9× 61 0.7× 16 0.3× 32 434
Tatsuya Usui Japan 12 334 1.5× 44 0.3× 111 1.2× 80 0.9× 23 0.4× 19 506
Dawn A. Bradbury United Kingdom 8 149 0.7× 78 0.6× 81 0.9× 60 0.7× 120 2.1× 9 396
Ashok K. Dilly United States 9 187 0.8× 39 0.3× 50 0.6× 48 0.6× 37 0.6× 12 365
Angela M. Bair United States 7 169 0.8× 160 1.3× 31 0.3× 50 0.6× 40 0.7× 7 444
Sarah Ruuska United States 7 514 2.3× 61 0.5× 47 0.5× 55 0.6× 33 0.6× 12 666

Countries citing papers authored by Héloïse M. Leclair

Since Specialization
Citations

This map shows the geographic impact of Héloïse M. Leclair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Héloïse M. Leclair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Héloïse M. Leclair more than expected).

Fields of papers citing papers by Héloïse M. Leclair

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Héloïse M. Leclair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Héloïse M. Leclair. The network helps show where Héloïse M. Leclair may publish in the future.

Co-authorship network of co-authors of Héloïse M. Leclair

This figure shows the co-authorship network connecting the top 25 collaborators of Héloïse M. Leclair. A scholar is included among the top collaborators of Héloïse M. Leclair based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Héloïse M. Leclair. Héloïse M. Leclair is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Baietti, Maria Francesca, et al.. (2022). The AhR‐SRC axis as a therapeutic vulnerability in BRAFi ‐resistant melanoma. EMBO Molecular Medicine. 14(12). e15677–e15677. 19 indexed citations
2.
Bachelot, Laura, Marc Aubry, Delphine Leclerc, et al.. (2021). CRISPR screens identify tumor‐promoting genes conferring melanoma cell plasticity and resistance. EMBO Molecular Medicine. 13(5). e13466–e13466. 21 indexed citations
3.
Leclair, Héloïse M., et al.. (2020). Role of Flavonoids in the Prevention of AhR-Dependent Resistance During Treatment with BRAF Inhibitors. International Journal of Molecular Sciences. 21(14). 5025–5025. 11 indexed citations
4.
Corre, Sébastien, Nicolas Mouchet, Héloïse M. Leclair, et al.. (2018). Sustained activation of the Aryl hydrocarbon Receptor transcription factor promotes resistance to BRAF-inhibitors in melanoma. Nature Communications. 9(1). 4775–4775. 81 indexed citations
5.
Harford‐Wright, Elizabeth, Gwennan André‐Grégoire, Kathryn Jacobs, et al.. (2017). Pharmacological targeting of apelin impairs glioblastoma growth. Brain. 140(11). 2939–2954. 70 indexed citations
6.
Dwyer, Julie, Sandy Azzi, Héloïse M. Leclair, et al.. (2015). The guanine exchange factor SWAP70 mediates vGPCR-induced endothelial plasticity. Cell Communication and Signaling. 13(1). 11–11. 9 indexed citations
7.
Azzi, Sandy, et al.. (2015). Desert Hedgehog/Patch2 Axis Contributes to Vascular Permeability and Angiogenesis in Glioblastoma. Frontiers in Pharmacology. 6. 281–281. 16 indexed citations
8.
Dubois, Sonia M., Catherine Alexia, Youtong Wu, et al.. (2014). A catalytic-independent role for the LUBAC in NF-κB activation upon antigen receptor engagement and in lymphoma cells. Blood. 123(14). 2199–2203. 82 indexed citations
9.
Leclair, Héloïse M., Sonia M. Dubois, Sandy Azzi, et al.. (2014). Control of CXCR2 activity through its ubiquitination on K327 residue. BMC Cell Biology. 15(1). 38–38. 15 indexed citations
10.
Dwyer, Julie, Héloïse M. Leclair, Catherine Alexia, et al.. (2013). YGLF motif in the Kaposi sarcoma herpes virus G-protein-coupled receptor adjusts NF-κB activation and paracrine actions. Oncogene. 33(49). 5609–5618. 12 indexed citations
11.
Dubois, Sonia M., Héloïse M. Leclair, Catherine Alexia, et al.. (2013). Negative regulation of NF-κB signaling in T lymphocytes by the ubiquitin-specific protease USP34. Cell Communication and Signaling. 11(1). 25–25. 27 indexed citations
12.
Hebda, Jagoda K., Héloïse M. Leclair, Sandy Azzi, et al.. (2013). The C-terminus region of β-arrestin1 modulates VE-cadherin expression and endothelial cell permeability. Cell Communication and Signaling. 11(1). 37–37. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takayuki Tsujioka Breakdown of academic impact, for papers by Riccardo Ferro Breakdown of academic impact, for papers by Satoko Masuda Breakdown of academic impact, for papers by Bin Yuan Breakdown of academic impact, for papers by Hui‐Jun Mu Breakdown of academic impact, for papers by Tatsuya Usui Breakdown of academic impact, for papers by Dawn A. Bradbury Breakdown of academic impact, for papers by Ashok K. Dilly Breakdown of academic impact, for papers by Angela M. Bair Breakdown of academic impact, for papers by Sarah Ruuska
Rankless by CCL
2026